Financing, Equity Capital Markets

Akoya Biosciences, Inc.

06/23
|
$50.0 Million
Akoya
Piper Sandler served as bookrunner for Akoya Biosciences, Inc. on a confidentially marketed follow on offering
Sub-Type
Confidentially Marketed Follow-On Offering
Sub-Sector
Tools & Diagnostics